Clinical Trial Update: Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated insulin glulisine versus insulin aspart and insulin lispro delivered by continuous subcutaneous insulin infusion in patients with Type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin aspart (insulin aspart)
• Insulin glulisine (insulin glulisine)
• insulin lispro (insulin lispro)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 1 | Phase 4 | Status: COMPLETED | Results posted: 2010-07-30